XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings (Loss) per Share
 6 Months Ended
Jun. 30, 2021
Earnings (Loss) per Share
NOTE 13 – Earnings (Loss) per share:
Basic earnings and loss per share are computed by dividing net results attributable to Teva’s ordinary shareholders by the weighted average number of ordinary shares outstanding (including fully vested restricted share units (“RSUs”)) during the period, net of treasury shares.
In computing diluted earnings per share for the three months ended June 30, 2021 and June 30, 2020, basic earnings per share were adjusted to take into account the potential dilution that could occur upon the exercise of options and
non-vested
RSUs granted under employee stock compensation plans.
No
account was taken of the potential dilution by the convertible senior debentures, since they had an anti-dilutive effect on earnings per share.
In computing diluted earnings per share for the six months ended June 30, 2021 and June 30, 2020, basic earnings per share were adjusted to take into account the potential dilution that could occur upon the exercise of options and
non-vested
RSUs granted under employee stock compensation plans.
No
account was taken of the potential dilution by the convertible senior debentures, since they had an anti-dilutive effect on earnings per share.
Basic and diluted earnings per share were $
0.19
for the three months ended June 30, 2021, compared to basic and diluted earnings per share of $
0.13
for the three months ended June 30, 2020.
Basic and diluted earnings per share were
 
$
0.26
for the
six
months ended June 
30
,
2021
, compared to basic and diluted
earnings
per share of $
0.19
for the
six
months ended June 
30
,
2020
.